Structure-function analysis of the FCRL5–IgG1 Fc complex reveals an unappreciated pathway for B cell modulation by Fc-attenuated IgG
Science Advances · 2026
DOI: 10.1126/sciadv.aei1233 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Bart M Herpers und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, University of Texas at Austin, Austin, TX, USA. Hauptthemen laut MEDLINE: Immunoglobulin G, B-Lymphocytes, Receptors, Fc, Immunoglobulin Fc Fragments. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIAID NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
The Fc region of therapeutic IgG antibodies is often engineered to remove or “silence” Fc effector functions, but it remains unclear whether these mutations eliminate all Fc-mediated effector activity. Human Fc receptor-like 5 (FCRL5/FcRH5) is a low-affinity IgG Fc receptor expressed on B cells and is an actively pursued antibody target in multiple myeloma. Here, we show that common Fc function-silencing mutations do not impair FCRL5-mediated activity and therefore attenuate, rather than eliminate, Fc effector function. The crystal structure of the FCRL5-IgG1 Fc complex, solved at 3.4 Å resolution, revealed that FCRL5 binds IgG1 Fc in a 1:1 complex through a binding mode distinct from that of classical Fcγ receptors, explaining why mutations that attenuate Fc effector function spare FCRL5 binding. Fc-engineered antibodies that selectively engage FCRL5 inhibited B cell receptor-induced Ca 2+ flux in FCRL5-expressing B cells. These findings demonstrate that Fc-attenuated therapeutic IgG retains the ability to engage FCRL5, identifying an unappreciated pathway for B cell modulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, University of Texas at Austin, Austin, TX, USA.
- Department of Molecular Biosciences, University of Texas at Austin, Austin, TX, USA.
- Department of Chemical Engineering, University of Texas at Austin, Austin, TX, USA.
- Department of Chemistry, University of Texas at Austin, Austin, TX, USA.
ORCID-Profile: Bart M Herpers, Mo Guo, George Delidakis, Jin Eyun Kim, Chang-Han Lee, Jennifer S Brodbelt, Y Jessie Zhang, George Georgiou
Förderung
- NIGMS NIH HHS
- NIAID NIH HHS
- National Institutes of Health
- Welch Foundation
- Argonne National Laboratory, Office of Science
- Clayton Foundation
- L. Leon Campbell Professorship
Zitieren
APA
Herpers, B. M., Guo, M., Ko, S., Delidakis, G., Kim, J. E., Lee, C. H., Gadallah, M. I., Brodbelt, J. S., Zhang, Y. J., & Georgiou, G. (2026). Structure-function analysis of the FCRL5–IgG1 Fc complex reveals an unappreciated pathway for B cell modulation by Fc-attenuated IgG. Science Advances. https://doi.org/10.1126/sciadv.aei1233
Vancouver
Herpers BM, Guo M, Ko S, Delidakis G, Kim JE, Lee CH, et al. Structure-function analysis of the FCRL5–IgG1 Fc complex reveals an unappreciated pathway for B cell modulation by Fc-attenuated IgG. Science Advances. 2026. doi:10.1126/sciadv.aei1233
BibTeX
@article{Herpers2026,
author = {Herpers, Bart M and Guo, Mo and Ko, Sanghwan and Delidakis, George and Kim, Jin Eyun and Lee, Chang-Han and Gadallah, Mohamed I and Brodbelt, Jennifer S and Zhang, Y Jessie and Georgiou, George},
title = {Structure-function analysis of the FCRL5–IgG1 Fc complex reveals an unappreciated pathway for B cell modulation by Fc-attenuated IgG},
journal = {Science Advances},
year = {2026},
doi = {10.1126/sciadv.aei1233}
}
EUVIMED